 6abc.com | SIMPONI (GOLIMUMAB) Receives FDA Approval For Ulcerative Colitis PipelineReview.com (press release) HORSHAM, PA, USA I May 15, 2013 I Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONIĀ® (golimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients ... FDA: Arthritis drug OKed to treat bowel disease |
